Suppr超能文献

微卫星稳定和不稳定结肠癌细胞中的基因表达变化。

Gene expression variations in microsatellite stable and unstable colon cancer cells.

机构信息

Department of Surgery, City of Hope Medical Center, 1500 E. Duarte Road, Duarte, CA 91010, USA.

出版信息

J Surg Res. 2012 May 1;174(1):1-6. doi: 10.1016/j.jss.2011.06.016. Epub 2011 Jul 7.

Abstract

BACKGROUND

Microsatellite instability (MSI) is a marker of chemoresistance, but it is associated with improved survival compared with microsatellite-stable (MSS) colon cancers. We hypothesized that MSI tumors overexpress chemoresistance-associated genes and underexpress DNA damage/repair genes. We used ultra high-throughput sequencing (UHTS) to assess the expression of representative genes in MSI and MSS colon cancer cell lines.

METHODS

Solexa UHTS was used to examine gene expression in HCT116 (MSI) and HT29 (MSS) cells, and normal colonic mucosa (NCM). We compared expression of 40 genes involved in chemoresistance, DNA repair, DNA damage, and drug metabolism pathways.

RESULTS

We observed gene expression differences between MSI and MSS cell lines in 8 out of 40 genes involved in mismatch repair (MMR), DNA repair, drug metabolism, and chemoresistance. MMR gene expression was lower in MSI cells, which is consistent with the MSI phenotype, whereas DNA repair genes were highly expressed in these cells. Genes associated with chemoresistance and drug metabolism also had increased expression in MSI cells. No difference in expression of DNA damage genes was observed between MSI and MSS cell lines.

CONCLUSION

Using UHTS gene expression analysis, we identified differential expression of genes between MSI and MSS cell lines which may account for resistance to chemotherapy in MSI tumors. UHTS expression analysis has the potential to identify genome-wide predictors of response or resistance to chemotherapy.

摘要

背景

微卫星不稳定性(MSI)是化疗耐药的标志物,但与微卫星稳定(MSS)结肠癌相比,它与生存改善相关。我们假设 MSI 肿瘤过度表达化疗耐药相关基因,而低表达 DNA 损伤/修复基因。我们使用超高通量测序(UHTS)来评估 MSI 和 MSS 结肠癌细胞系中代表性基因的表达。

方法

Solexa UHTS 用于检查 HCT116(MSI)和 HT29(MSS)细胞以及正常结肠黏膜(NCM)中的基因表达。我们比较了 40 个参与化疗耐药、DNA 修复、DNA 损伤和药物代谢途径的基因的表达。

结果

我们观察到 40 个涉及错配修复(MMR)、DNA 修复、药物代谢和化疗耐药的基因中,有 8 个基因在 MSI 和 MSS 细胞系之间存在基因表达差异。MSI 细胞中 MMR 基因表达较低,这与 MSI 表型一致,而这些细胞中 DNA 修复基因高度表达。与化疗耐药和药物代谢相关的基因在 MSI 细胞中也有增加的表达。MSI 和 MSS 细胞系之间未观察到 DNA 损伤基因表达的差异。

结论

使用 UHTS 基因表达分析,我们确定了 MSI 和 MSS 细胞系之间基因表达的差异,这可能解释了 MSI 肿瘤对化疗的耐药性。UHTS 表达分析有可能识别出对化疗反应或耐药的全基因组预测因子。

相似文献

1
Gene expression variations in microsatellite stable and unstable colon cancer cells.
J Surg Res. 2012 May 1;174(1):1-6. doi: 10.1016/j.jss.2011.06.016. Epub 2011 Jul 7.
3
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Cancer Chemother Pharmacol. 2010 Sep;66(4):659-67. doi: 10.1007/s00280-009-1206-3. Epub 2009 Dec 24.
4
A novel approach for characterizing microsatellite instability in cancer cells.
PLoS One. 2013 May 6;8(5):e63056. doi: 10.1371/journal.pone.0063056. Print 2013.
8
Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
J Natl Cancer Inst. 2016 Dec 31;109(5). doi: 10.1093/jnci/djw272. Print 2017 May.
9

引用本文的文献

3
Multi-glycomic analysis of spheroid glycocalyx differentiates 2- and 3-dimensional cell models.
Glycobiology. 2023 Jan 8;33(1):2-16. doi: 10.1093/glycob/cwac075.
4
Midostaurin Modulates Tumor Microenvironment and Enhances Efficacy of Anti-PD-1 against Colon Cancer.
Cancers (Basel). 2022 Oct 4;14(19):4847. doi: 10.3390/cancers14194847.
5
6
Profiling of hepatocellular carcinoma neoantigens reveals immune microenvironment and clonal evolution related patterns.
Chin J Cancer Res. 2021 Jun 30;33(3):364-378. doi: 10.21147/j.issn.1000-9604.2021.03.08.
7
PPARγ induces PD-L1 expression in MSS+ colorectal cancer cells.
Oncoimmunology. 2021 May 5;10(1):1906500. doi: 10.1080/2162402X.2021.1906500.
8
Global histone modification fingerprinting in human cells using epigenetic reverse phase protein array.
Cell Death Discov. 2017 Mar 6;3:16077. doi: 10.1038/cddiscovery.2016.77. eCollection 2017.
10
Gene expression in colon cancer: A focus on tumor site and molecular phenotype.
Genes Chromosomes Cancer. 2015 Sep;54(9):527-41. doi: 10.1002/gcc.22265. Epub 2015 Jul 14.

本文引用的文献

1
Clinical relevance of microsatellite instability in colorectal cancer.
J Clin Oncol. 2010 Jul 10;28(20):3380-7. doi: 10.1200/JCO.2009.27.0652. Epub 2010 Jun 1.
2
Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch?
J Clin Oncol. 2010 Jul 10;28(20):3207-10. doi: 10.1200/JCO.2010.28.9314. Epub 2010 May 24.
3
Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
J Clin Oncol. 2010 Jul 10;28(20):3219-26. doi: 10.1200/JCO.2009.27.1825. Epub 2010 May 24.
4
Microsatellite instability in colorectal cancer-the stable evidence.
Nat Rev Clin Oncol. 2010 Mar;7(3):153-62. doi: 10.1038/nrclinonc.2009.237. Epub 2010 Feb 9.
5
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Cancer Chemother Pharmacol. 2010 Sep;66(4):659-67. doi: 10.1007/s00280-009-1206-3. Epub 2009 Dec 24.
6
The DNA-damage response in human biology and disease.
Nature. 2009 Oct 22;461(7267):1071-8. doi: 10.1038/nature08467.
7
Enhanced cytotoxicity of 5-FU by bFGF through up-regulation of uridine phosphorylase 1.
Mol Cells. 2009 Aug 31;28(2):119-24. doi: 10.1007/s10059-009-0116-x. Epub 2009 Aug 20.
8
Digital transcriptome profiling using selective hexamer priming for cDNA synthesis.
Nat Methods. 2009 Sep;6(9):647-9. doi: 10.1038/nmeth.1360. Epub 2009 Aug 9.
9
Comparison of next generation sequencing technologies for transcriptome characterization.
BMC Genomics. 2009 Aug 1;10:347. doi: 10.1186/1471-2164-10-347.
10
Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy.
Biochem Pharmacol. 2009 Dec 1;78(11):1366-73. doi: 10.1016/j.bcp.2009.07.006. Epub 2009 Jul 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验